Google
×

Figitumumab

Drug
Figitumumab is a monoclonal antibody targeting the insulin-like growth factor-1 receptor that was investigated for the treatment of various types of cancer, for example adrenocortical carcinoma and non-small cell lung cancer. Wikipedia
Find Assistance and Support Resources For Eligible Patients. A Lilly Medicine. Learn How RetevmoŽ Works And How It May Help You. Official Site. Dosing and Administration. About RetevmoŽ. Savings & Support.